– 10.1% CC YoY Revenue Growth in Q3 Leads to Upward Revision in Guidance
“With increased client relevance, we saw double digit (10.1%) year-on-year growth in Q3 on a constant currency basis,” said Salil Parekh, CEO and MD. “We also had another strong quarter in our digital business with 33.1% growth and large deals at $1.57 billion which gives us confidence entering 2019”, he added.
8.5%-9.0% Revision in FY 19 Guidance in CC terms
2.7% QoQ revenue growth in CC terms
33.1% YoY Digital revenue growth in CC terms
$1.5 Bn+ Large deal signings
22.6%* Operating margin
*Includes additional depreciation and amortization impact of 0.4% due to reclassification of assets of Panaya and Skava from “Held for Sale.”
1. FinancialHighlights- ConsolidatedresultsunderInternationalFinancialReportingStandards(IFRS)
For the Quarter ended December 31, 2018- Revenues were $2,987 million, growth of 8.4% YoY and 2.2% QoQ
– Operating profit was $675 million, growth of 0.9% YoY and decline of 2.6% QoQ#
– Basic EPS was $0.12, decline of 33.9% YoY@ and 13.6% QoQ#
For nine months ended December 31, 2018
– Revenues were $8,740 million, growth of 7.4% YoY
– Operating profit was $2,038 million, growth of 3.7% YoY
– Basic EPS was $0.37, decline of 11.3% YoY##@
# Includes additional depreciation and amortization expenses of $12 million for Panaya and Skava. Additionally, Basic EPS includes reduction in fair value of Skava which together resulted in a reduction in EPS by $0.02.
##Includes additional depreciation and amortization expenses, reduction in fair value and carrying value of Panaya and Skava, respectively which resulted in a reduction in EPS by $0.03.
@Includes impact on account of conclusion of an APA with the US IRS which has led to an increase in EPS of $0.05 for the quarter and nine months ended December 31, 2017.
“Volume growth was strong and revenue productivity was stable despite Q3 being a seasonally weak quarter. We had good growth across geographies and large business segments,” said Pravin Rao, COO. “Attrition declined during the quarter and we are continuing on the path of increased interventions and employee engagements to reduce it further.”
“We saw significant currency volatility during the quarter and managed it effectively by our hedging strategy,” said Jayesh Sanghrajka, Interim CFO. “Cash generation was strong during the quarter. Executing on the capital allocation strategy announced in April 2018, we have announced a share buyback program and a special dividend.”
2. Capital Allocation Policy
The Board in its meeting held today approved the following:
After the execution of the above, along with the special dividend (including dividend distribution tax) of ₹2,633 crore ($386 million) already paid in June 2018, the Company would complete the distribution of ₹13,000 crore, which was announced as part of its capital allocation policy in April 2018.
As the USD/INR* exchange rates have moved from April 2018 when the capital allocation policy was announced, the total capital allocation in US$ terms amounts to $1,872 million (comprising $1,184 million pertaining to buyback as mentioned above, $386 million towards special dividend paid in June 2018 and $302 million towards special dividend to be paid to shareholders in January 2019).
*US$ 1= ₹69.78 as at December 31, 2018
3. Assets Held for Sale
The company had earlier classified its subsidiaries Kallidus & Skava (together referred to as “Skava”) and Panaya as “Held for Sale”. During the quarter ended December 31, 2018, based on evaluation of proposals received and progress of negotiations with potential buyers, the Company concluded that it is no longer highly probable that sale would be consummated by March 31, 2019. Accordingly, Panaya and Skava have been de-classified from “held for sale” in accordance with the requirements of IFRS 5.
On de-classification, the Company recognized additional depreciation and amortization expenses of $12 million and a reduction of $65 million in the carrying value for Skava. The impact of the same on the Basic Earnings Per Share was a decrease of $0.02 for the quarter ended December 31, 2018.The Company plans to repurpose Skava’s micro services based business and refocus Panaya’s suite of products.
4. Board Update
Based on the recommendation of the Nomination and Remuneration Committee, the Board approved the re-appointment of Kiran Mazumdar-Shaw as the Lead Independent Director from April 1, 2019 to March 22, 2023, subject to shareholder’ approval.
“I am delighted that the Infosys Board of Directors has unanimously recommended Kiran Mazumdar-Shaw for reappointment as the Lead Independent Director,” said Nandan Nilekani, Chairman of the Board. “Kiran has been a pillar of strength to the board, especially over the last eighteen months as we steered the company to stability and growth. As chair of the Nominations & Remuneration Committee, she played a critical role in the CEO and CFO selection process. Her continuity, experience and insights are greatly valued by the Board as it guides the company in executing its strategy in the coming years,” he added.
Infosys is a global leader in next-generation digital services and consulting. We enable clients in 45 countries to navigate their digital transformation. With over three decades of experience in managing the systems and workings of global enterprises, we expertly steer our clients through their digital journey. We do it by enabling the enterprise with an AI-powered core that helps prioritize the execution of change. We also empower the business with agile digital at scale to deliver unprecedented levels of performance and customer delight. Our always-on
learning agenda drives their continuous improvement through building and transferring digital skills, expertise, and ideas from our innovation ecosystem.
Visit www.infosys.com to see how Infosys (NYSE: INFY) can help your enterprise navigate your next.
Certain statements mentioned in this release concerning our future growth prospects are forward-looking statements regarding our future business expectations intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2018. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Commission and our reports to shareholders. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the company unless it is required by law.
Infosys Limited and subsidiaries
Audited Condensed Consolidated Balance Sheet as at
(Dollars in millions except equity share data)
December 31, 2018 March 31, 2018 ASSETS Current assets Cash and cash equivalents 2,357 3,041 Current investments 1,407 982 Trade receivables 2,130 2,016 Unbilled revenue 688 654 Prepayments and other current assets 776 662 Derivative financial instruments 60 2 7,418 7,357 Assets held for sale(4)(5) – 316 Total current assets 7,418 7,673 Non-current assets Property, plant and equipment 1,817 1,863 Goodwill 514 339 Intangible assets 108 38 Investment in associate – – Non-current investments 650 883 Deferred income tax assets 174 196 Income tax assets 932 931 Other non-current assets 259 332 Total non-current assets 4,454 4,582 Total assets 11,872 12,255 LIABILITIES AND EQUITY Current liabilities Trade payables 219 107 Derivative financial instruments – 6 Current income tax liabilities 247 314 Client deposits 5 6 Unearned revenue 434 352 Employee benefit obligations 229 218 Provisions 83 75 Other current liabilities 1,190 1,036 2,407 2,114 Liabilities directly associated with assets held for sale(4)(5) – 50 Total current liabilities 2,407 2,164 Non-current liabilities Deferred income tax liabilities 76 82 Employee benefit obligations 6 7 Other non-current liabilities 63 42 Total liabilities 2,552 2,295 Equity Share capital- ₹5 ($0.16) par value 4,800,000,000 (2,400,000,000) equity shares authorized, issued and outstanding 4,347,938,160 (2,173,312,301), net of 20,709,738 (10,801,956) treasury shares as at December 31, 2018 (March 31, 2018), respectively 340 190 Share premium 268 247 Retained earnings 11,252 11,587 Cash flow hedge reserve 5 – Other reserves 385 244 Capital redemption reserve 9 9 Other components of equity (2,947) (2,317) Total equity attributable to equity holders of the company 9,312 9,960 Non-controlling interests 8 – Total equity 9,320 9,960 Total liabilities and equity 11,872 12,255
Infosys Limited and subsidiaries
Audited Condensed Consolidated Statement of Comprehensive Income for the (Dollars in millions except equity share and per equity share data)
Three months Three months Nine months Nine months ended ended ended ended December 31, December 31, December 31, December 31, 2018 2017 2018 2017 Revenues 2,987 2,755 8,740 8,134 Cost of sales 1,956 1,773 5,660 5,208 Gross profit 1,031 982 3,080 2,926 Operating expenses Selling and marketing expenses 161 136 464 405 Administrative expenses 195 177 578 555 Total operating expenses 356 313 1,042 960 Operating profit 675 669 2,038 1,966 Other income, net(3) 105 149 317 413 Reduction in the fair value of Disposal Group held for sale(4) – – (39) – Adjustment in respect of excess of carrying amount over recoverable amount on reclassification from “Held for Sale”(5) (65) – (65) – Share in net profit/(loss) of associate, including impairment(6) – – – (11) Profit before income taxes 715 818 2,251 2,368 Income tax expense(7) 213 22 633 453 Net profit 502 796 1,618 1,915 Other comprehensive income Items that will not be reclassified subsequently to profit or loss: Re-measurements of the net defined benefit liability/asset, net (4) 2 (3) 3 Equity instruments through other comprehensive income, net 8 – 10 – Items that will be reclassified subsequently to profit or loss: Fair valuation of investments, net 6 (4) (3) 2 Fair value changes on derivatives designated as cash flow hedge, net 8 1 5 (6) Foreign currency translation 295 229 (634) 182 Total other comprehensive income/(loss), net of tax 313 228 (625) 181 Total comprehensive income 815 1,024 993 2,096 Profit attributable to: Owners of the Company 502 796 1,618 1,915 Non-controlling interests – – – – 502 796 1,618 1,915 Total comprehensive income attributable to: Owners of the Company 815 1,024 993 2,096 Non-controlling interests – – – – 815 1,024 993 2,096 Earnings per equity share(8) Basic ($) 0.12 0.17 0.37 0.42 Diluted ($) 0.12 0.17 0.37 0.42 Weighted average equity shares used in computing earnings per equity share(8) 4,347,673,46 4,564,373,54 Basic 6 4,550,149,608 4,347,130,342 2 4,352,731,38 4,568,574,98 Diluted 7 4,552,763,140 4,352,705,150 4